Patent ID: 11873289
Assignee: MYOKARDIA, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC A  C  B  Y | IPC B  C

Claim 13:
14. The process of claim 3, wherein converting the compound of formula III to a compound of formula II is carried out using alkylating agent selected from the group consisting of bromoalkane, chloroalkane, iodoalkane, diazoalkane, dialkylcarbonate, dialkylsulfonate in the presence of a base selected from sodium hydride, potassium hydride, sodium ethoxide, sodium methoxide, lithium tert-butoxide, sodium tert-butoxide, potassium tert-butoxide, triethylamine, n-butylamine, t-butylamine, pyridine, methyl lithium, n-butyl lithium, lithium diisopropyl amide, lithium 2,2, 6,6-tetramethylpiperidine, sodium bis(trimethylsilyl)amide, lithium bis(trimethylsilyl)amide, potassium bis(trimethylsilyl)amide, and lithium diethylamide.